ClinicalTrials.gg
Drug

Iloprost clinical trials

Also written Ventavis, Ilomedin and ZK 36374.

studies test it
62
open now
4
in phase 3
15
first study started
1995

How each study uses Iloprost is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Iloprost studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Dec 2004 · VENTAVIS · NDA 021779 (FDA, Drugs@FDA)
European Union
15 Sept 2003 · Ventavis · EMEA/H/C/000474 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Iloprost
34
Inhaled iloprost
7
Iloprost infusion
2
Iloprost Clathrate
2
iloprost nebuliser solution
2

Brand

Ventavis
19
Ilomedin
7
Ciloprost
2

Development codes

ZK 36374
2
SUB08136MIG
1

Studies by the year they started

61 studies that test it; most in 2006 (9); 1 more planned to start later

Studies that test Iloprost, by start year
YearStudies
19951
19971
19981
20001
20011
20052
20069
20071
20085
20092
20104
20112
20126
20131
20142
20154
20162
20173
20181
20194
20203
20221
20242
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
8
Phase 2
27
Phase 3
15
Phase 4
8
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 48

Actelion (8) · Pär Johansson (4) · Yonsei University (3) · Bayer (3) · Charite University, Berlin, Germany (3) · University of Oklahoma (2) · National Cancer Institute (NCI) (2) · Shanghai Jiao Tong University School of Medicine (2)

Often tested with

Tested in the same studies.

Eptifibatide (2) · Treprostinil (1) · Sildenafil (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Iloprost.

Studies

Open first, then newest update. How each study uses Iloprost is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 62

See all 62 studies that test Iloprost →

What changed recently

From the registry's own updates since Oct 20, 2026.

Codes

What other systems call Iloprost · ClinicalTrials.gg INT008525

  • MeSH (NLM) D016285IloprostConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) JED5K35YGLILOPROSTConfirmed FDA, NLM, Wikidata
  • RxNorm 40138Confirmed FDA, Wikidata
  • Wikidata Q20817139iloprostConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C48397IloprostOne source FDA
  • DrugBank DB01088One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.